Rebalix
Logo Franklin TempletonFranklin Templeton · sheet of 10 September 2026
ETF sheet · official issuer and register data

Franklin Emerging Markets Sovereign Debt Values UCITS ETF

CATHEM · IE000YZIVX22 · class SINGLCLASS · USD · domicile Ireland
Bonds · Government · Broad (all maturities) · Emerging marketsSFDR art. 8
Index tracked: ICE Emerging Markets ESG Values External Sovereign Index
TER
0.35%+ trans. 0.19%
Fund size
59 m EUR
Tracking difference
−0.76%3-year avg
🇮🇹 tax rate
15.77%white list 75.79%
Replication
Physical (optimised)
Income
Accumulating
Duration
6.48 yrsmedium (3–7 years)
Launch 27 Jun 2022 · costs from the KID as of 2 Sept 2026 · 74 securities held · 9 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 2 Sept 2026
Investment Objective To provide exposure to Euro- and US Dollar-denominated sovereign debt issued by emerging market countries. Investment Policy The Fund invests in government bonds issued in emerging markets and denominated in EUR or USD. These may be fixed or floating rate and some of them may be below investment grade. These investments are included in the benchmark. The Index is based on the ICE BofA Diversified Emerging Markets External Debt Sovereign Bond Index (the “Parent Index”) and is comprised of US Dollar- and Euro- denominated sovereign…

Performance since series start (in euro) — base 100

30 Jun 202231 Jul 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
202320242025202611899115
High 118 (30 Jun 2026) · low 99 (31 Oct 2022) · last 115. Past performance is not indicative of future results.

Returns in euro

1 year+7.1%
3 years+12.8%
5 yearsseries too young
10 yearsseries too young
Since series start+14.8%

Risk · 1 / 3 / 5 years

Volatility (ann.)4.40%5.42%
Max drawdown−4.39%−7.44%
Sharpe-0.070.61
Sortino-0.100.91
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · CATHEM · IE000YZIVX221
RebalixCATHEM · IE000YZIVX22 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+13.61%+14.79%−1.18%
2024−0.82%−0.19%−0.63%
2023+10.25%+10.72%−0.48%

Fixed income — as declared by the issuer

Issuer page · 2 Sept 2026

Holdings

Portfolio as declared by the issuer · 26 Aug 2026 · 74 securities · top-10 weight = 28.2%
Countries (% of fund)
Polonia10.1%Romania9.2%Argentina7.3%Brasile7.2%Filippine7.1%

Listing venues

ESMA register (FIRDS) and official exchange lists
CATHEM · Borsa Italiana (ETFplus)
FLCV · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 15 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.franklintempleton.ie/download/en-ie/key-information-document/74d06
Factsheet · www.franklintempleton.ie/download/en-ie/factsheet/51bbfd47-c937-4a1d-b
Prospectus · www.franklintempleton.ie/download/en-ie/prospectus/77b538e3-0d06-42a0-
The live sheet, always up to date
rebalix.com/en/etf/IE000YZIVX22
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · CATHEM · IE000YZIVX222